These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26155747)

  • 1. Circulating microRNAs and diabetes: potential applications in medical practice.
    Raffort J; Hinault C; Dumortier O; Van Obberghen E
    Diabetologia; 2015 Sep; 58(9):1978-92. PubMed ID: 26155747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MicroRNAs in Type 2 Diabetes and Associated Vascular Complications.
    Banerjee J; Nema V; Dhas Y; Mishra N
    Biochimie; 2017 Aug; 139():9-19. PubMed ID: 28487136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients.
    Al-Kafaji G; Al-Mahroos G; Abdulla Al-Muhtaresh H; Sabry MA; Abdul Razzak R; Salem AH
    Biomarkers; 2017; 22(3-4):268-278. PubMed ID: 27321479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease.
    Rawal S; Manning P; Katare R
    Cardiovasc Diabetol; 2014 Feb; 13():44. PubMed ID: 24528626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA as a diagnostic marker in populations with type 2 diabetes mellitus and diabetic complications.
    Chien HY; Lee TP; Chen CY; Chiu YH; Lin YC; Lee LS; Li WC
    J Chin Med Assoc; 2015 Apr; 78(4):204-11. PubMed ID: 25529478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving beyond mean glycemia: 1,5-anhydroglucitol and microvascular complications of diabetes.
    Lawler PR; Mora S
    Clin Chem; 2014 Nov; 60(11):1359-61. PubMed ID: 25217368
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?
    Sebastiani G; Nigi L; Grieco GE; Mancarella F; Ventriglia G; Dotta F
    J Endocrinol Invest; 2017 Jun; 40(6):591-610. PubMed ID: 28213644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and Cardiovascular Disease in Diabetes Mellitus.
    Ding Y; Sun X; Shan PF
    Biomed Res Int; 2017; 2017():4080364. PubMed ID: 28299324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma prorenin in diabetes mellitus and its correlation with some complications.
    Franken AA; Derkx FH; Man in't Veld AJ; Hop WC; van Rens GH; Peperkamp E; de Jong PT; Schalekamp MA
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1008-15. PubMed ID: 2205621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent knowledge on the biochemistry and function of insulin and the effects of insufficient secretion and activity of the hormone].
    Kolb E
    Z Gesamte Inn Med; 1983 Sep; 38(17):453-60. PubMed ID: 6356658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs: Promising Biomarkers Involved in Several Cancers and Other Diseases.
    Zhao Y; Song Y; Yao L; Song G; Teng C
    DNA Cell Biol; 2017 Feb; 36(2):77-94. PubMed ID: 28060535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs as biomarkers for metabolic disease.
    Párrizas M; Novials A
    Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):591-601. PubMed ID: 27923453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochemistry of circulating lymphocytes in diabetes mellitus with and without retinopathy and in newly diagnosed type I (insulin dependent) diabetes.
    Solerte SB; Invernizzi R; Fioravanti M; Schianca GC; Bozzetti A; Girino M; Bertolino G; Ferrari E
    Acta Histochem; 1986; 80(2):225-34. PubMed ID: 3101378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of blood insulin determination in diagnosis of diabetes mellitus and its theoretical basis].
    Kosaka K; Kajinuma H; Sando H; Hagura R
    Nihon Rinsho; 1973 Jul; 31(7):2218-26. PubMed ID: 4582288
    [No Abstract]   [Full Text] [Related]  

  • 16. MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications.
    Olivieri F; Spazzafumo L; Bonafè M; Recchioni R; Prattichizzo F; Marcheselli F; Micolucci L; Mensà E; Giuliani A; Santini G; Gobbi M; Lazzarini R; Boemi M; Testa R; Antonicelli R; Procopio AD; Bonfigli AR
    Oncotarget; 2015 Nov; 6(34):35372-82. PubMed ID: 26498351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?
    Fichtlscherer S; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2383-90. PubMed ID: 22011751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of flavonoid-rich fruit and vegetable intake on diabetic retinopathy and diabetes-related biomarkers.
    Mahoney SE; Loprinzi PD
    J Diabetes Complications; 2014; 28(6):767-71. PubMed ID: 25055729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome.
    Mavrakanas T; Frachebois C; Soualah A; Aloui F; Julier I; Bastide D
    Presse Med; 2009 Oct; 38(10):1399-403. PubMed ID: 19419831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.